Protective effects of pharmacological therapies in animal models of multiple sclerosis: a review of studies 2014–2019

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system. The disability caused by inflammatory demyelination clinically dominates the early stages of relapsing-remitting MS and is reversible. Once there is considerable loss of axons, MS patients enter a seconda...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez, Bridget, Peplow, Philip V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047782/
https://www.ncbi.nlm.nih.gov/pubmed/31960801
http://dx.doi.org/10.4103/1673-5374.272572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047782/
https://www.ncbi.nlm.nih.gov/pubmed/31960801
http://dx.doi.org/10.4103/1673-5374.272572

Ejemplares similares